The Plateau State Government has officially flagged off the 2026 Seasonal Malaria Chemoprevention (SMC) campaign as part of efforts to protect children from malaria and further reduce the disease burden across the state.
The flag-off ceremony, held at the Crispan Event Center in Jos, brought together government officials, health practitioners, development partners, and other stakeholders committed to improving child health and malaria prevention.
The campaign is aimed at providing life-saving preventive malaria medication to eligible children during the peak malaria transmission season.
Speaking at the event, the Plateau State Commissioner for Health, Dr. Nicholas Ba’amlong, commended the First Lady of Plateau State, Barr. Helen Mutfwang, for her commitment to the programme as the 2026 SMC Ambassador.
He noted that her support and advocacy had contributed significantly to efforts aimed at protecting children from malaria across the state.
Dr. Ba’amlong also praised the State Malaria Elimination Programme, Malaria Consortium, development partners, and frontline health workers for their roles in implementing seasonal malaria prevention initiatives that have helped reduce malaria cases in Plateau State.
The Commissioner further appreciated Governor Caleb Mutfwang for prioritizing the health sector and providing strong support for healthcare programmes in the state.
He called on all stakeholders, including community leaders and wives of local government chairmen, to support the campaign to ensure its success.
During the event, the First Lady of Plateau State, Barr. Helen Mutfwang, was officially crowned the 2026 Ambassador of the Seasonal Malaria Chemoprevention campaign in recognition of her advocacy and commitment to the health and well-being of women and children.
Addressing participants, Barr. Mutfwang described the flag-off of the SMC campaign as another major step towards protecting children from malaria and improving public health across Plateau State.
She expressed delight over the progress recorded in malaria control, revealing that malaria prevalence in the state had dropped from 18.8 percent in 2021 to 2.8 percent in 2025 through the combined efforts of government, healthcare workers, communities, and development partners.
“This achievement demonstrates that with strong leadership, effective partnerships, and community participation, malaria can be defeated,” she said.
The First Lady urged parents and caregivers to ensure that eligible children receive the free SMC medicines during every cycle of the campaign.
She also commended Governor Caleb Mutfwang, Malaria Consortium, healthcare workers, and community volunteers for their contributions to the fight against malaria before officially flagging off the campaign.
Speaking during the event, Nurse Ndak Kizito Zuhumnan, Program Manager of the Plateau State Malaria Elimination Program, explained that the exercise was designed to mobilize stakeholders and communities to protect children from malaria during the peak transmission season.
He disclosed that community drug distributors, health workers, and supervisors would commence house-to-house visits from June to October to administer preventive malaria medicines to children aged three to 59 months across the state.
“The aim of this medication is to prevent children from coming down with malaria. We want to reach over one million children, and we urge parents and guardians to make every eligible child available for this free and safe intervention,” he stated.
Zuhumnan noted that Plateau State had recorded remarkable success in malaria control, attributing the achievement largely to the SMC programme and sustained collaboration among government agencies, health workers, development partners, the media, and community leaders.
In a goodwill message delivered on behalf of the West and Central Africa Programme Director of Malaria Consortium, Dr. Maxwell Kolawole, Dr. Mbwas Mashor commended the Plateau State Government and its partners for their commitment to malaria control efforts.
He stated that despite Nigeria’s high malaria burden, Plateau State had achieved significant progress in reducing malaria prevalence through sustained interventions and effective partnerships.
Dr. Mashor disclosed that the 2026 SMC campaign would target over one million eligible children across the state.
He reaffirmed Malaria Consortium’s continued support for malaria elimination efforts and called for stronger government ownership, sustained funding, and continued collaboration to sustain the gains already achieved.
Also speaking, the Chairman of the Association of Primary Healthcare, Chundung Maina, commended Plateau State for its commitment to strengthening the health system through data-driven planning and implementation.
She noted that the progress recorded in the state reflected stronger political will, improved investment, and effective use of evidence in public health decision-making.
According to her, Plateau State is increasingly gaining national recognition as a model for health sector improvement, adding that sustained commitment and adequate financing remain critical to consolidating and expanding the gains already achieved in the health sector.
Former Nigerian Head of State Abdulsalami Abubakar has been featured in promotional material by an Indian hospital following his knee replacement surgery there.
The video, which has gone viral on social media, shows Mr Abubakar receiving care at Krishna Shalby Hospital in Ahmedabad, India, including footage of him walking and exercising after the procedure.
The hospital has also used images of the former Head of State and Vice President Kashim Shettima in posts promoting its services to international patients.
Hospital’s promotion
In an Instagram post on Monday, the Indian Hospital said Mr Shettima visited the facility and met its management to discuss Mr Abubakar’s progress and wellbeing.
The hospital described the visit as a reflection of the “growing trust in India’s healthcare” and its commitment to caring for patients from across the world.
“When patients travel across borders for specialised care, their trust means everything,” the hospital said.
It is not immediately clear whether Mr Abubakar’s treatment was fully sponsored by the federal government.
The law also provides other benefits, including diplomatic passports, protocol privileges, official vehicles, office and residential accommodation, security and annual vacation at federal government expense.
In 2026, the federal government budget provides N2.3 billion for the entitlements of former presidents, Heads of State and their deputies.
Nigerians react
The hospital’s use of Mr Abubakar’s treatment in its promotional material has generated reactions from Nigerians.
Activist and presidential candidate Omoyele Sowore was among those who reacted after sharing the promotional video on X on Tuesday.
“This is former Nigerian Head of State, General Abdulsalami Abubakar, being used in a hospital advert after undergoing knee replacement surgery in India,” Mr Sowore said.
He questioned why Nigerian leaders who had opportunities while in government to develop the country’s healthcare system continue to seek specialised treatment abroad.
Mr Sowore said the development was a reflection of what he described as “decades of failed leadership and neglect of Nigeria’s healthcare system”.
Aloy Ejimafor, a barrister, also criticised the development in a Facebook post.
Mr Ejimafor described it as a “diplomatic insult” for an Indian hospital to use Mr Abubakar’s image in an advert for knee replacement surgery in India.
Medical tourism
Mr Abubakar’s treatment abroad comes amid a long-running pattern of Nigerian political leaders seeking medical care outside the country.
For instance, late President Muhammadu Buhari faced repeated criticismover his medical trips to the United Kingdom during his presidency.
Nigerian doctors and other critics argued that the practice undermined confidence in the country’s health system, particularly because political leaders control public investment in healthcare.
In April 2025, Coordinating Minister of Health and Social Welfare, Muhammad Pate, said Nigeria loses an estimated $2 billion annually to medical tourism.
Mr Pate made the statement at the commissioning of a 50-bed specialist hospital in Lagos, where he said the figure reflected gaps in confidence, access and quality in the country’s healthcare system.
“This is not just about stopping medical tourism. It is about building health sovereignty, the ability of a country to care for its own people, develop its institutions, talent, and innovation,” Mr Pate said.
Discover more from Premium Times Nigeria
Subscribe to get the latest posts sent to your email.
Nigeria has been identified among high-volume markets where a new $1 testing package could help expand screening of pregnant women for HIV, syphilis and hepatitis B.
The package, launched by Premier Medical Corporation and Impact Nexus Africa, combines two rapid diagnostic tests under a single commercial offer for use through existing antenatal care services.
The companies said their analysis identified Nigeria, Ethiopia, Tanzania, Uganda, Kenya, Mozambique and South Africa among the countries with the largest potential markets for antenatal hepatitis B screening.
Impact Nexus Africa estimates that the package could generate about $215 million in commodity savings across 74 low- and middle-income countries between 2026 and 2035, if adopted across antenatal care at the modelled volumes.
However, the estimate is based on modelling and does not represent confirmed savings for individual countries, including Nigeria.
How the package works
The Triple Elimination Testing Bundle costs $1 ex-works per woman screened and contains two separate rapid diagnostic tests.
One is the World Health Organisation’s (WHO)-prequalified First Response HIV 1+2/Syphilis Combo Card Test, which screens for HIV and syphilis simultaneously.
The second is the First Response hepatitis B surface antigen (HBsAg) Card Test, which screens for a marker of hepatitis B infection.
The tests remain separate products but are supplied together as a single commercial offer.
The price also includes access to digital training, assessment and competency tools for end users.
The $1 price excludes freight, local distribution, taxes, regulatory costs and other programme or implementation expenses. Orders are subject to a minimum quantity of 100,000 bundles.
Potential savings
According to the companies, the package is between 22 per cent and 46 per cent cheaper in commodity terms than procuring equivalent HIV/syphilis and hepatitis B rapid diagnostic tests separately.
The analysis estimates an addressable market of about 37.8 million antenatal HBsAg tests annually across 74 low- and middle-income countries.
It projects that using the package instead of separately procured tests could generate about $215 million in commodity savings over 10 years.
The companies said annual savings could exceed $10 million in some high-volume markets, while they could remain below US$1 million in smaller markets.
Actual savings, however, would depend on countries’ existing procurement prices, testing volumes and the scale and pace of implementation, according to the analysis.
They also estimate that the modelled rollout could identify HBsAg-positive pregnancies in about 17.1 million women and contribute to averting approximately 2.7 million infant hepatitis B infections between 2026 and 2035.
It said the health impact projections depend on screening uptake, local hepatitis B prevalence and successful linkage of women who test positive to recommended maternal and infant interventions.
Why hepatitis B screening matters
The initiative is aimed at supporting the global effort to eliminate mother-to-child transmission of HIV, syphilis and hepatitis B.
The WHO recommendstesting pregnant women for HIV, syphilis and hepatitis B at least once during pregnancy and as early as possible.
While HIV and syphilis screening have increasingly been incorporated into antenatal care, hepatitis B screening remains less consistently implemented across countries.
The companies said the new package could therefore serve both countries that already provide hepatitis B screening and those seeking to introduce or expand it.
They said the approach builds on existing antenatal care systems rather than requiring countries to establish a separate testing platform.
What the package could mean for Nigeria
For Nigeria, the significance of the package goes beyond its lower price.
A 2026 analysisof Nigeria Demographic and Health Survey data found that although 72 per cent of mothers attended antenatal care, only 12.3 per cent were tested for hepatitis B during pregnancy.
Earlier national data also highlightedthe gap. An analysis of about 2.8 million pregnant women who received antenatal care across more than 6,000 facilities providing prevention of mother-to-child transmission services found that only 7.2 per cent were screened for hepatitis B.
The Federal Ministry of Health and Social Welfare has also been working to strengthen hepatitis B screening as part of Nigeria’s triple-elimination response. In 2025, the ministry saidit planned to introduce free hepatitis B testing, treatment and care for pregnant women who test positive.
Against this backdrop, the new bundle could offer Nigeria a lower-cost option for expanding hepatitis B screening through existing antenatal care services.
The companies said the package is available to public and private sector purchasers across all low and middle-income countries, subject to national registration, importation and procurement requirements.
Discover more from Premium Times Nigeria
Subscribe to get the latest posts sent to your email.